TL;DR
This paper compares two high-throughput sequencing (HTS) methods for identifying viruses in the blood of patients with unexplained febrile illness in Tanzania. Both methods successfully identified known viruses, demonstrating HTS's utility in outbreak investigations, with VirCapSeq-VERT showing higher sensitivity and unbiased sequencing offering better coverage of viral genome ends.
What Problem Does This Paper Address?
Diagnosing the cause of febrile illnesses, especially in resource-limited settings, can be challenging. Traditional methods like PCR and culture are targeted and may miss novel or co-infecting viruses. High-throughput sequencing (HTS) offers a broader approach to identify viral pathogens, but different HTS strategies have varying strengths and weaknesses. This paper addresses the need to compare two prominent HTS methods – unbiased sequencing and a targeted positive selection method (VirCapSeq-VERT) – for their effectiveness in characterizing the plasma virome of patients with unexplained febrile illness, a common diagnostic challenge.
Methods
The study employed two distinct HTS approaches to analyze plasma samples from 12 patients in Tanzania with unexplained febrile illness:
- Unbiased HTS: This method involves sequencing all nucleic acids present in the sample after treating with DNase to remove DNA. Libraries were prepared and sequenced on Illumina HiSeq 4000 and HiSeq 2500 platforms. Data analysis involved a pipeline that included demultiplexing, quality filtering, host-subtraction, and alignment to a curated viral database.
- VirCapSeq-VERT: This is a targeted HTS method that uses a probe set designed to capture viral RNA and DNA, specifically focusing on coding sequences. Nucleic acid extraction was followed by library preparation, pooling, hybridization with the VirCapSeq-VERT probe set, and sequencing on an Illumina HiSeq 4000 system. Bioinformatic analysis involved adaptor trimming, quality filtering, host-subtraction, and assembly of remaining reads.
Both methods were compared for their ability to identify viruses, genome coverage, and sensitivity. PCR assays were used to confirm findings from the sequencing data.
Datasets
The study utilized plasma samples collected from 12 adult patients with unexplained febrile illness in Dar es Salaam, Tanzania, between August 2013 and April 2014. These samples were part of a larger observational cohort. Malaria was excluded as a cause of fever in these patients through rapid diagnostic tests and qPCR.
Key Insights and Ideas
- HTS as a powerful diagnostic tool: The study reinforces that HTS is a valuable method for identifying viral pathogens in clinical samples, particularly in cases where the cause of illness is unclear.
- Complementary strengths of HTS methods: Unbiased sequencing and VirCapSeq-VERT, while both effective, offer different advantages. Unbiased sequencing is better for discovering novel viruses and characterizing the full viral genome, including non-coding regions, while VirCapSeq-VERT excels at sensitive detection of known viruses and achieving deep coverage of coding sequences.
- Importance of comprehensive viral surveillance: The identification of multiple viruses (Dengue virus 2, West Nile virus, HIV-1, human pegivirus, and Epstein-Barr virus) in a small cohort highlights the potential for co-infections and the need for broad-spectrum diagnostic approaches.
- VirCapSeq-VERT's efficiency: This method reduces the need for extensive sample preprocessing (like rRNA depletion) and simplifies bioinformatic analysis due to its targeted nature.
Key Results
- Both unbiased HTS and VirCapSeq-VERT successfully identified viral sequences in the plasma samples.
- Dengue virus 2 (DV2) was identified in 4 out of 12 samples, suggesting a potential outbreak during the study period.
- Human immunodeficiency virus type 1 (HIV-1), West Nile virus (WNV), human pegivirus (HPgV), and Epstein-Barr virus (EBV) were also detected in various samples.
- VirCapSeq-VERT demonstrated higher sensitivity, detecting viruses in samples where they were present at lower titers or missed by conventional PCR.
- Unbiased sequencing provided better coverage of the non-coding sequences at the termini of viral genomes, which is crucial for applications like reverse genetics.
- Nearly complete viral genomes were recovered for multiple viruses in samples with coinfections.
Limitations and Future Work
- Causality: The study acknowledges that while HTS can identify viral candidates, it is insufficient on its own to establish a causal link to disease. Further investigation is needed to determine which detected viruses are responsible for the febrile illness.
- Cost and Complexity: The authors note that the cost and complexity of HTS analysis currently limit its widespread application in routine diagnostics, although this is expected to change as technology advances.
- Database Dependence: The accuracy of HTS is dependent on the completeness and quality of the reference viral databases used for analysis.
- Future Directions: The paper suggests that as costs decrease and analysis platforms improve, unbiased HTS and targeted methods like VirCapSeq-VERT will become increasingly valuable for timely and important microbiological information, aiding in outbreak response. The ongoing development and updating of probe sets for VirCapSeq-VERT are also highlighted as important for its continued utility.
Summary updated